Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, October 4, 2016

Public edition |

Newswise Cancer Research Wire for 04-Oct-2016

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

UCSF Helen Diller Family Comprehensive Cancer Center Joins National Effort to Improve Survival for Pancreatic Cancer Patients

The UCSF Helen Diller Family Comprehensive Cancer Center is one of only 12 academic centers in the U.S. joining a large national precision medicine study that aims to improve survival for pancreatic cancer patients. The trial, called Precision Promis...

– UCSF Helen Diller Family Comprehensive Cancer Center

Embargo expired on 04-Oct-2016 at 06:00 ET

Yale Study Identifies New Way to Suppress Lung Tumors

A Yale-led research team has identified a new blocking mechanism that acts like a dimmer switch and inhibits lung tumor cell growth....

– Yale Cancer Center

Nature Chemical Biology

Bladder Cancer Research Rife with New Approaches

The FDA approval of Tecentriq ushered in the first new treatment for advanced bladder cancer in 30 years....

– Yale Cancer Center

Determining Free Speech for Students: When Does Interpretation Play a Part?

In the fall of 2010, some female public middle school students began wearing the Keep a Breast Foundation’s “I ♥ Boobies” wristbands and distributing them to classmates to raise awareness, show support, and open a dialogue about breast cancer...

– National Communication Association

First Amendment Studies

Antibody Drug Conjugates May Help Personalize Radiotherapy for Patients with Cancer

Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to ra...

– University of California San Diego Health Sciences

Nature Communications

Breast Density Matters in Detection of Breast Cancer

Almost 8% of women have extremely high breast density, which can make it harder for health professionals to detect breast cancer on a screening mammogram. These women are also more likely to develop breast cancer in the future....

– University of Adelaide

MicroRNA Specifically Kills Cancer Cells with Common Mutation

Approximately 20 percent of all human cancers have mutations in a gene called <i>KRAS</i>. <i>KRAS</i>-mutant cancers are among the most difficult to treat, with poor survival and resistance to chemotherapy. Researchers at University of California Sa...

– University of California San Diego Health Sciences

Cancer Research

Embargo expired on 03-Oct-2016 at 00:05 ET

Scientists Identify Protein Involved in Restoring Effectiveness of Common Treatment for Breast Cancer

Breast cancer is the most frequently diagnosed cancer among women, with estrogen-receptor-positive (ER+) being the most common type. Drugs used to treat this cancer, such as tamoxifen and Faslodex, block the hormone estrogen receptor that ER+ cancer ...

– Wake Forest Baptist Medical Center

Cancer Research, Oct - 2016

Embargo expired on 03-Oct-2016 at 00:00 ET

Inhibiting Production of One Protein Restores Treatment Benefit in Resistant Breast Cancer

In animal models of human breast cancer, inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers....

– Georgetown Lombardi Comprehensive Cancer Center

Cancer Research; DOD Breast Cancer Research Program Postdoctoral Fellowship BC112023; NCI Career Transition Award 1K22CA181274-01A1; US Department of Health and Human Services R01-CA131465, U01-CA184902 and U54-CA149147...

Embargo expired on 03-Oct-2016 at 00:05 ET

High Up-Front Costs Could Delay Access to Life-Saving Blood Cancer Drugs for Medicare Patients

In the study published in the Journal of Clinical Oncology, UNC Lineberger researchers report that nearly a third of a group of patients with chronic myeloid leukemia, and who have federally-funded Medicare health insurance, did not start treatment w...

– University of North Carolina Health Care System

Journal of Clinical Oncology, Oct-2016

Embargo expired on 03-Oct-2016 at 16:00 ET

New Therapeutic Target in Non-Hodgkin's Lymphoma, Killing Mutant Cancers with mRNA, Vulnerability in Treatment-Resistant Lung Cancer, and MORE in the Cancer News Source

Click here to go directly to the Cancer News Source...

– Newswise

Competition Between Wolverines and Badgers Helps Raise More Than $5.9 M for Childhood Cancer Research

Michigan wins more than a football game on Saturday....

– University of Michigan Health System

Study Reports Innovative Combination of Minimally Invasive Procedures Laser Interstitial Thermotherapy (LITT) & ‘Mini’ Craniotomy for Treating ‘Inoperable’ Brain Tumors

A new paper in the October issue of the journal Neurosurgical Focus finds the use of laser beneficial for the removal of large, “inoperable” glioblastoma (GBM) and other types of brain tumors. The authors describe how they treated larger, inoper...

– University Hospitals Cleveland Medical Center

Gene Found That Raises Risk of Childhood Ear Infections

Researchers have discovered a gene region that raises the risk a child will have a middle ear infection, known to doctors as acute otitis media—and known to parents as one reason for a screaming, unhappy preschooler. The finding may offer an early ...

– Children's Hospital of Philadelphia

Nature Communications, published online Sept. 28, 2016; HG006830

Virtual Reality Program Enhances Treatment for Young Cancer Patients

The University of Southern California (USC) Norris Comprehensive Cancer Center has partnered with Springbok Cares to provide a unique Virtual Reality initiative for patients in the Adolescent and Young Adult Cancer program at USC. ...

– Keck Medicine of USC

Scotiabank Road Hockey to Conquer Cancer Breaks Two World Records

On Saturday October 1st, Scotiabank Road Hockey to Conquer Cancer faced off for its sixth hugely successful year. This year, 1786 players and their donors raised $2.5 million! ...

– University Health Network (UHN)

Renowned Lung Cancer Expert to Join NYU Langone as Chief of Hematology and Medical Oncology

The Perlmutter Cancer Center at NYU Langone Medical Center has named noted clinician-scientist Kwok-Kin Wong, MD, PhD, as its new Chief of Hematology and Medical Oncology. ...

Expert Available

– NYU Langone Medical Center

Seattle Cancer Care Alliance Opens Prostate Cancer Genetics Specialty Clinic

SEATTLE – (Sept. 20, 2016) – Seattle Cancer Care Alliance (SCCA) has opened a new Prostate Cancer Genetics Clinic at their South Lake Union campus in Seattle. The specialty clinic will serve patients with prostate cancer that has spread beyond th...

Expert Available

– Seattle Cancer Care Alliance

NYU Researchers Conduct Study with Innovative, Electronic, and Mobile Self-Care Tools to Help Early Identification and Treatment of Lymphedema

The development of TOLF was motivated by the request from breast cancer survivors in our prior research where nurse-patient-in-person delivery model was used and guided by the Model of Self-Care for Lymphedema Symptom Management based on our prior re...

– New York University

mHealth (July 2016)

New Research Shows HPV Vaccine Reduces Cervical Pre-Cancers In Young Women

New research published Sept 29, 2016, in JAMA Oncology shows the HPV vaccine is efficacious in reducing cervical pre-cancers among young women throughout a population. The New Mexico HPV Pap Registry was the data source used in the study. The researc...

– University of New Mexico Comprehensive Cancer Center

JAMA Oncology

Embargo expired on 29-Sep-2016 at 11:00 ET

Ovarian Removal to Prevent Ovarian Cancer Should Not Be an Option for Premenopausal Women, Mayo Research Finds

A Mayo Clinic research team has found evidence suggesting that the controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be discontinued in women who are not at high risk of cancer. ...

– Mayo Clinic

Embargo expired on 29-Sep-2016 at 08:00 ET

NYU Lutheran Names Cancer Surgeon to Lead New Outreach Program

Looking to advance its scope of cancer care and create further synergies between cancer-related subspecialties, NYU Lutheran recently named Ioannis “Yanni” Hatzaras, MD, to direct its Surgical Oncology Outreach Program....

– NYU Lutheran Medical Center

Embargo expired on 29-Sep-2016 at 09:00 ET

NUS-Led Study: Consumption of a Bioactive Compound From Neem Plant Could Significantly Suppress Development of Prostate Cancer

A team of international researchers led by Associate Professor Gautam Sethi from the Department of Pharmacology at the Yong Loo Lin School of Medicine at the National University of Singapore has found that nimbolide, a bioactive terpenoid compound de...

– National University of Singapore

Antioxidants & Redox Signaling Volume: 24 Issue 11: April 14, 2016

Memorial Sloan Kettering Researchers Engineer “Micro-Pharmacies” in CAR T Cells to Treat B Cell Lymphomas

There has been much recent excitement about immunotherapy and the use of genetically engineered chimeric antigen receptor (CAR) T cells. Historically, CAR T cell immunotherapy has aimed to boost the immune system by giving immune cells the informatio...

– Memorial Sloan Kettering Cancer Center

Immediate Breast Reconstruction Reduces Psychological Impact of Mastectomy

Immediate breast reconstruction (IBR) can avoid some of the psychological effects of undergoing mastectomy for breast cancer, compared to waiting for delayed breast reconstruction (DBR), reports a study in the October issue of Plastic and Reconstru...

– Wolters Kluwer Health: Lippincott Williams and Wilkins

Plastic and Reconstructive Surgery

UTSW Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer

Researchers working in four labs at UT Southwestern Medical Center have found a chink in a so-called “undruggable” lung cancer’s armor – and located an existing drug that might provide a treatment....

– UT Southwestern Medical Center


New Clinical Trial Will Test Cancer Drug as Alzheimer’s Treatment

The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna® for use a...

– Alzheimer's Drug Discovery Foundation

Cardiac Risk a Factor When Considering Hormonal Therapy for Prostate Cancer

In a recent study, a Yale Cancer Center team determined that men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack. ...

– Yale Cancer Center

Embargo expired on 28-Sep-2016 at 15:00 ET

Nanoparticle Creates ‘Wave of Destruction’ in Cancer Cells

Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer. Now, the ultrasmall particles have shown they can do something even better: kill cancer cells without attaching a...

– Cornell University

Particular HPV Strain Linked to Improved Prognosis for Throat Cancer

Findings of improved survival for patients with a type of head and neck cancer linked to HPV-16, and comparatively worse outcomes for other HPV strains, have treatment implications....

– University of North Carolina Health Care System

Oral Oncology

Principal Investigators at The Wistar Institute Have Secured Nearly $14 Million in Funding

Wistar scientists have received nearly $1...

– Wistar Institute

On the Road with Data Science

Randy Olson, PhD, a senior data scientist with Penn’s Institute for Biomedical Informatics (IBI), started publishing optimized road trip maps, and now uses his analytical skills to tackle some of biomedicine's biggest questions. ...

– Perelman School of Medicine at the University of Pennsylvania

Tumor Paint Brings Light to Toddler’s Brain Tumor

Hunter Coffman was diagnosed with a brain tumor at Seattle Children’s when he was 2-years-old. While preparing for the surgery to remove the tumor, Hunter’s parents were also presented with the opportunity to enroll Hunter in Seattle Children’s...

– Seattle Children's Hospital

How a Teddy Bear Is Helping in the Battle Against Cancer

A team at Seattle Children’s Research Institute came up with an idea to make a life-changing moment feel a little more personal for patients undergoing immunotherapy. A teddy bear wearing a mask and purple cape, aptly named T-Bear, is given to pat...

– Seattle Children's Hospital

University of Southern California to Show How Wearable Technology Can Improve Cancer Treatment

Researchers at the University of Southern California will demonstrate how using wearable technology and smartphones can improve cancer treatment at a White House event on Oct. 3. The USC project will be one of the participants in the Cancer Moonshot ...

– University of Southern California (USC)

Radiation Boost Reduces Local Tumor Recurrence for DCIS Patients Following WBRT

A supplemental “boost” of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) fo...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 27-Sep-2016 at 13:30 ET

Optimal Management for NSCLC Patients with Brain Metastases

A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly diagnosed EGFR-mutant non-small cell lung cancer (NSCLC) with brain metastases to determine the best option for treatment. ...

– Yale Cancer Center

Link Between Facility Volume and Radiation Outcomes for Head and Neck Cancers

The association between provider case volume and outcomes has long been suggested in cancer care. A Yale Cancer Center team has completed a review of outcomes for patients with locally advanced squamous cell head and neck cancers treated with intensi...

– Yale Cancer Center

Radiation Boost Reduces Local Tumor Recurrence for DCIS Patients Following WBRT

A supplemental “boost” of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) fo...

– Yale Cancer Center

Freezing Technique Is an Effective Alternative to Lumpectomy for Early Stage Breast Cancer, Study Finds

A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers, NewYork-Presbyterian and Weill Cornell Medicine researchers find in a new clinical study. The results are published in ...

– New York-Presbyterian Hospital

Annals of Surgical Oncology

Breast Cancer Patients Benefit Physically From Mental Health Support

Psycho-social factors can impact how a woman deals with -- and recovers from -- breast cancer....

– Rowan University

Tackling Obesity in Rural Communities

Currently, excess body weight contributes to as many as 1 in 5 cancer-related deaths. Obesity is associated with increased risk of at least eight types of cancer. The American Society of Clinical Oncology has identified obesity as a health risk that ...

– University of Kansas Cancer Center

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age. ...

Expert Available

– University of Texas M. D. Anderson Cancer Center

Policy and Public Affairs

Patients and Providers: Women at Risk of Losing Mammography Insurance Coverage

If Congress does not act, millions of women may lose insurance coverage for annual mammograms. Patient groups, minority health care advocates and breast cancer experts urge Congress to extend a federal mandate that effectively requires insurers to fu...

– American College of Radiology (ACR)


New NCCN Patient Resources Assist Decision-Making for People with Stomach Cancer

NCCN has published new patient education materials for Stomach Cancer; these resources are available to download free of charge at

– National Comprehensive Cancer Network® (NCCN®)

$250K Grant Supports Examination of Drug Compound on Common Cancer Mutation

A $250,000 grant from the Breast Cancer Research Foundation awarded to a Rutgers Cancer Institute of New Jersey researcher will help further elucidate the inner workings of the p53 gene. The work will examine a drug compound that restores tumor suppr...

– Rutgers Cancer Institute of New Jersey

UCLA Lung Transplant Program Performs Landmark 1000th Surgery

The UCLA Lung Transplant program performed its 1,000th transplant surgery in mid-September, becoming the first program on the West Coast, and one of only seven centers nationwide, to achieve this milestone....

– University of California, Los Angeles (UCLA), Health Sciences

Immunotherapy Authority Joins Rush Cancer Leadership

A leading authority on developing innovative immunotherapy treatments is Rush' new division chief of the Hematology, Oncology and Cell Therapy. Dr. Dr. Timothy Kuzel, a leading expert on cancer immunotherapies, will focus on continuing to assemble m...

– Rush University Medical Center

Seattle Cancer Care Alliance Opens Prostate Cancer Genetics Specialty Clinic

Seattle Cancer Care Alliance (SCCA) has opened a new Prostate Cancer Genetics Clinic at their South Lake Union campus in Seattle. The specialty clinic will serve patients with prostate cancer that has spread beyond the prostate (metastatic) and/or wh...

– Seattle Cancer Care Alliance

New England Journal of Medicine

Houston Methodist Receives $9 Million Federal Grant to Study Physics of Cancer Immunotherapy

Houston Methodist received $9 million from the National Cancer Institute to establish the Center for Immunotherapeutic Transport Oncophysics (CITO). CITO combines the studies of cancer immunology, nanotechnology and the physics of cancer biology. CIT...

– Houston Methodist

National Cancer Institute

Higher Education Events

NCCN Congress to Explore Complex Issues in Treating Hematologic Malignancies

The NCCN 11th Annual Congress: Hematologic Malignancies™ returns to New York City September 30 – October 1, 2016; registration is still open at

– National Comprehensive Cancer Network® (NCCN®)

Expert Pitch

Yale Cancer Center Expert Available to Discuss the FDA Approval of Tecentriq in the Treatment of Bladder Cancer.

– Yale Cancer Center

Prostate Cancer Expert Lee Ponsky, MD, of University Hospitals Seidman Cancer Center, Can Address Diagnosis, Treatment and Prognosis in Light of Ben Stiller's News of His 'Aggressive' Form of the Disease

– University Hospitals Cleveland Medical Center

Breast Cancer Awareness: What Women Need to Know

– New York Institute of Technology

Yale Cancer Center Expert Speaks About Survival and Treatment with Stereotactic Radiosurgery, in Combination with Targeted Therapy Using EGFR Tyrosine Kinase Inhibitors.

– Yale Cancer Center

Physician Can Comment on Benefit of Whole Breast Radiation Therapy Radiation (WBRT) Following Lumpectomy

– Yale Cancer Center





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:


 University of Texas M. D. Anderson Cancer Center

 Seattle Children's Hospital

 University of Southern California (USC)

 University of California San Diego Health Sciences

 Wolters Kluwer Health: Lippincott Williams and Wilkins

 UT Southwestern Medical Center

 University of Michigan Health System

 Seattle Cancer Care Alliance

 New York Institute of Technology

 University of California, Los Angeles (UCLA), Health Sciences

Subscribe / Unsubscribe
Edit my preferences

© 2016 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us